Supplement 25 May 2000

Alpha Blockade in Sexual Function

An international, multi-disciplinary meeting was held in Puerto Rico January 21 to 23, 1999, to discuss in consensus format the topic of `Alpha Blockade in Sexual Function'. The meeting was sponsored by an unrestricted educational grant from Schering Plough.

Preface

PREFACE

Preface25 May 2000 International Journal of Impotence Research

Acknowledgements

ACKNOWLEDGEMENTS
- Irwin Goldstein
- Harin Padma-Nathan
- Ray Rosen
Acknowledgements25 May 2000 International Journal of Impotence Research

Basic Science Research

Sympathetic pathways and adrenergic innervation of the penis
- K-E Andersson
- P Hedlund
- P Alm
Basic Science Research25 May 2000 International Journal of Impotence Research
Central noradrenergic control of penile erection
- F Giuliano
- O Rampin
Basic Science Research25 May 2000 International Journal of Impotence Research
Regulation of pre-synaptic alpha adrenergic activity in the corpus cavernosum
- I Saenz de Tejada
- NN Kim
- AM Traish
Basic Science Research25 May 2000 International Journal of Impotence Research
Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum
- NN Kim
- I Goldstein
- AM Traish
Basic Science Research25 May 2000 International Journal of Impotence Research
Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue
- A Giraldi
- M Wyllie
- G Wagner
Basic Science Research25 May 2000 International Journal of Impotence Research
Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells
- A Traish
- NN Kim
- RB Moreland
Basic Science Research25 May 2000 International Journal of Impotence Research
Role of alpha adrenergic receptors in erectile function
- A Traish
- NN Kim
- I Goldstein
Basic Science Research25 May 2000 International Journal of Impotence Research

Clinical Research

Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385)
- J Bancroft
Clinical Research25 May 2000 International Journal of Impotence Research
Yohimbine in erectile dysfunction: the facts
- A Morales
Clinical Research25 May 2000 International Journal of Impotence Research
Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction
- I Goldstein
Clinical Research25 May 2000 International Journal of Impotence Research
Comparison of oral and intracavernosal vasoactive agents in penile erection
- T Lue
- I Goldstein
- A Traish
Clinical Research25 May 2000 International Journal of Impotence Research

Alpha Blockade in Sexual Function

Preface

PREFACE

Acknowledgements

ACKNOWLEDGEMENTS

Basic Science Research

Sympathetic pathways and adrenergic innervation of the penis

Central noradrenergic control of penile erection

Regulation of pre-synaptic alpha adrenergic activity in the corpus cavernosum

Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum

Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue

Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells

Role of alpha adrenergic receptors in erectile function

Clinical Research

Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385)

Yohimbine in erectile dysfunction: the facts

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

Comparison of oral and intracavernosal vasoactive agents in penile erection

Search

Quick links